| Thomas Edward Wyatt, MD | |
|
4050 Coon Rapids Blvd, Coon Rapids, MN 55433 | |
| (763) 236-7144 | |
| (763) 236-7733 |
| Full Name | Thomas Edward Wyatt |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 24 Years |
| Location | 4050 Coon Rapids Blvd, Coon Rapids, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427025642 | NPI | - | NPPES |
| 313697300 | Medicaid | MN | |
| 45311 | Other | MN MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 45311 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hennepin County Medical Center 1 | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hennepin Healthcare System Inc | 4789684861 | 794 |
News Archive
Through their pattern of firing, neurons influence the behavior of the cells that upon maturation will provide insulation of neuronal axons, according to a new study publishing 22 August in the open access journal PLOS Biology by Balint Nagy, Maria Kukley and colleagues at the University of Tübingen, Germany.
Argentinian researchers from the Centro de Investigaciones de Plagas e Insecticidas have developed a new trap that can be used to effectively monitor and control the Aedes aegypti mosquito, which is the primary transmitter of Zika, dengue, chikungunya, and yellow fever. The trap is described in the Journal of Medical Entomology.
The Canadian Public Health Association opens its doors this Sunday June, 13, 2010 to the public, introducing a walking tour of the 12 great achievements of public health in Canada. The 15,000 square foot CPHA Centenary EXPO titled This is Public Health features a dynamic display of visuals that highlights the importance of public health and its fundamental impact on the health of Canadians over the last 100 years.
Reclast (zoledronic acid) Injection has been approved by the US Food and Drug Administration (FDA) as the first and only therapy to prevent postmenopausal osteoporosis for two years with a single dose. Reclast is already approved as a once-yearly infusion for the treatment of postmenopausal osteoporosis.
In a recent paper published in PLOS One, Soumya Chatterjee, M.D., assistant professor of infectious diseases, allergy and immunology at Saint Louis University, presents data to show that a focus on high-risk tuberculosis patients may be the answer to stalled progress in stamping out the illness in the United States.
› Verified 5 days ago
| Entity Name | Hennepin Healthcare System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138136 PECOS PAC ID: 4789684861 Enrollment ID: O20070207000467 |
News Archive
Through their pattern of firing, neurons influence the behavior of the cells that upon maturation will provide insulation of neuronal axons, according to a new study publishing 22 August in the open access journal PLOS Biology by Balint Nagy, Maria Kukley and colleagues at the University of Tübingen, Germany.
Argentinian researchers from the Centro de Investigaciones de Plagas e Insecticidas have developed a new trap that can be used to effectively monitor and control the Aedes aegypti mosquito, which is the primary transmitter of Zika, dengue, chikungunya, and yellow fever. The trap is described in the Journal of Medical Entomology.
The Canadian Public Health Association opens its doors this Sunday June, 13, 2010 to the public, introducing a walking tour of the 12 great achievements of public health in Canada. The 15,000 square foot CPHA Centenary EXPO titled This is Public Health features a dynamic display of visuals that highlights the importance of public health and its fundamental impact on the health of Canadians over the last 100 years.
Reclast (zoledronic acid) Injection has been approved by the US Food and Drug Administration (FDA) as the first and only therapy to prevent postmenopausal osteoporosis for two years with a single dose. Reclast is already approved as a once-yearly infusion for the treatment of postmenopausal osteoporosis.
In a recent paper published in PLOS One, Soumya Chatterjee, M.D., assistant professor of infectious diseases, allergy and immunology at Saint Louis University, presents data to show that a focus on high-risk tuberculosis patients may be the answer to stalled progress in stamping out the illness in the United States.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Edward Wyatt, MD 5435 Feltl Rd, Minnetonka, MN 55343-7983 Ph: (952) 835-9880 | Thomas Edward Wyatt, MD 4050 Coon Rapids Blvd, Coon Rapids, MN 55433 Ph: (763) 236-7144 |
News Archive
Through their pattern of firing, neurons influence the behavior of the cells that upon maturation will provide insulation of neuronal axons, according to a new study publishing 22 August in the open access journal PLOS Biology by Balint Nagy, Maria Kukley and colleagues at the University of Tübingen, Germany.
Argentinian researchers from the Centro de Investigaciones de Plagas e Insecticidas have developed a new trap that can be used to effectively monitor and control the Aedes aegypti mosquito, which is the primary transmitter of Zika, dengue, chikungunya, and yellow fever. The trap is described in the Journal of Medical Entomology.
The Canadian Public Health Association opens its doors this Sunday June, 13, 2010 to the public, introducing a walking tour of the 12 great achievements of public health in Canada. The 15,000 square foot CPHA Centenary EXPO titled This is Public Health features a dynamic display of visuals that highlights the importance of public health and its fundamental impact on the health of Canadians over the last 100 years.
Reclast (zoledronic acid) Injection has been approved by the US Food and Drug Administration (FDA) as the first and only therapy to prevent postmenopausal osteoporosis for two years with a single dose. Reclast is already approved as a once-yearly infusion for the treatment of postmenopausal osteoporosis.
In a recent paper published in PLOS One, Soumya Chatterjee, M.D., assistant professor of infectious diseases, allergy and immunology at Saint Louis University, presents data to show that a focus on high-risk tuberculosis patients may be the answer to stalled progress in stamping out the illness in the United States.
› Verified 5 days ago
Noel Pillman, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4050 Coon Rapids Blvd, Mercy Medical Center, Coon Rapids, MN 55433 Phone: 763-236-7144 Fax: 763-236-7733 | |
Alan Fuller, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4050 Coon Rapids Blvd, Mercy Medical Center, Coon Rapids, MN 55433 Phone: 763-236-7144 Fax: 763-236-7733 | |
Joseph P Lynch, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4050 Coon Rapids Blvd, Mercy Medical Center, Coon Rapids, MN 55433 Phone: 763-236-7144 Fax: 763-236-7733 | |
Ms. Amanda M Baker, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4050 Coon Rapids Blvd, Mercy Medical Center, Coon Rapids, MN 55433 Phone: 763-236-7144 Fax: 763-236-7733 | |
Jodi Greenlaw, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-236-6000 | |
Carl Blashko, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4050 Coon Rapids Blvd, Mercy Hospital, Coon Rapids, MN 55433 Phone: 763-236-7144 Fax: 763-236-7733 | |
Sharon Sweeney Carmody, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4050 Coon Rapids Blvd, Mercy Medical Center, Coon Rapids, MN 55433 Phone: 763-236-7144 |